Featured Posts

  

Dispatches From the Crossroads

Rss
Posted by: BIO Ventures for Global Health on 2/29/2012 | 0 Comments
The message at the Global Health Technologies Coalition’s recent Capitol Hill briefing was clear: millions of lives have been saved across the globe because of American innovation in global health. But the impact of global health is even greater than that. It spurs innovation to create new tools that fight against neglected tropical diseases and avert pandemics. It helps Americans travelling abroad and soldiers in the U.S. military. And -- what is likely most important to many Americans -- investing in research leads to the creation of new jobs as well as diplomacy advancements.
Posted by: BIO Ventures for Global Health on 2/1/2012 | 0 Comments
New CEO Don Joseph has just returned from London, where the Gates Foundation, in conjunction with the World Health Organization and 13 of the world’s largest pharmaceutical companies, announced a new effort to end or control ten neglected tropical diseases. As we work together to achieve this goal, he writes, it is important to acknowledge that poverty and the neglect of populations create the environment that allows these diseases to thrive.

  

Recent Comments

by Chad on Coffee Break
"It is really sad that third-world countries suffer so much from an assortment of diseases and we tend to live without worrying about it. Only in a perfect world could the public and privates sectors work together as a "super-power" to recognize and fix these problems, but as of the current economic conditions it seems to be fading even more. Honestly, this is such a sad moment for everyone!" Read more »

by Yina on A Shifting Paradigm?
"As a long time agent of change in the Healthcare space, I have seen the under uliaizttion of technology. It is not bleeding edge' technology that causes me concern but the more mature ones that have been poorly driven and implemented. Much of this can be attributed to the Change Management plan. We fail to fully vet pilot sites, we jam data and processing into the pipe without taking avantage of future implementations, we include the directly affected stakeholders long after implementation starts and we don't analyze the impact on systems and layered products needed for success. The resourcing and uliaizttion of analysts, technical tactitions and workflow specialtists is arduous and expensive (and often considered unnecessary). However, the reengineering of applications and lost hours due to disruption at the user end needs to be added to the cost algorithm. After all even a medium sized system implementation failure creates grief for anyone else trying to affect change in the same user environment." Read more »

by Christian on Crossing the Valley of Death
"If the NIH could find a way to get the CAN funded then we could get some more research and development on the way. Congress just needs to approve the funding for this project. Thanks..." Read more »